BIT's 7th Annual Symposium of Drug Delivery Systems (SDDS-2017)
★ Scientific Programme

BIT's 7th Annual International Symposium of

Drug Delivery Systems-2017

Time: July 12-14, 2017
Venue: Prague, Czech Republic

 

Scientific Program
Keynote Forum Track-1 Track-2 Track-3 Track-4
Track-5 Track-6 Track-7 -

 

 

 

 Track 1: Breaking Research in DDS 

Session 1-1: Enhancing Bioavailability with New Technologies and Strategies

Time: 13:30-17:10, July 12, 2017 (Wednesday)

Place: Prague C, 2nd Floor, Vienna House Diplomat Prague

Chair Dr. Dieter Lubda, Director, R&D Operations of Actives and Formulation, Merck KGaA, Germany
Co-chair

Dr. Tuula Ryde, Director, R&D Operations, iCeutica, USA

13:30-13:55   Title: Addressing Solubility and Bioavailability Challenges by Adapting Excipients to Innovative Technologies
Dr. Dieter Lubda,
Director, R&D Operations of Actives and Formulation, Merck KGaA, Germany
13:55-14:20 http://www.bitcongress.com/uploadfile/2016090510284273499.jpg Title: 50-year of Testing the Pharmacologically Active Drugs on Insects
Dr. Karel Slama, Director, Laboratory of Insect Physiology, Czech Republic
14:20-14:45 Title: The Influence of Drug Crystal Form on Drug Delivery System
Dr. Ailing Liu,
Director, Tianjin Ringpu Bio-technology Co., Ltd.; Professor, Tianjin University, China
14:45-15:10

Title: Application of Flow Techniques for Monitoring Dissolution, Liberation and Permeation Tests

Dr. Hana Sklenarova, Associate Professor, Charles University, Czech Republic
15:10-15:30 Coffee Break
15:30-15:55

Title: Oral Bioavailability Enhancement With SoluMatrix Fine Particle Technology™

Dr. Tuula Ryde, Director, R&D Operations, iCeutica, USA
15:55-16:20

Title: Application of Simultaneous Dissolution-absorption Apparatus to Predict Outcome of Bioequivalence Study

Dr. Balint Sinko, Manager, Technology Development and Support, Pion Inc., USA

16:20-16:45

Title: Benefits and Limitations of Using Cyclodextrins in Drug Formulations
Dr. István Puskás,
Head, Formulation Laboratory, Cyclolab Ltd., Hungary

16:45-17:10

 

 

Title: Liporaxel®, The World’s First Oral Paclitaxel Formulation
Dr. In-Hyun Lee, Team Leader, Drug Delivery System Team and Bio-Drug, Dae Hwa Pharm. Co. Ltd., South Korea

 

 

Session 1-2: Sustained-release, Controlled-release, and Modified-release

Time: 13:30-15:10, July 13, 2017 (Thursday)

Place: Prague C, 2nd Floor, Vienna House Diplomat Prague

Chair

Dr. Alan Y. Lu, Executive Vice President, Product Development, Sirnaomics, Inc., USA

13:30-13:55   Title: PVA - Revival of a Long Lost Polymer: From Solid Dispersion to Modified Release
Dr. Finn Bauer,
Director, Solid Formulations R&D, Merck KGaA, Germany
13:55-14:20 Title: Adare Pharmaceuticals Modified Release Solution for  Patient-Centric Formulation
Mr. Luigi Boltri, R&D Director, Innovation & Technology Liaison, Adare Pharmaceuticals, Italy
14:20-14:45 Title: Senescent-associated Nanoparticles as Selective Drug Delivery System
Dr. Andrea Bernardos, Senior Researcher, Universitat Politècnica de València; Senior Researcher, Ciber-BBN, Spain
14:45-15:10 Title: Using the Cucurbituril Cavity to Moderate Drug Release
Dr. Anthony Day, Researcher, University of New South Wales Canberra, Australia
15:10-15:30 Coffee Break

 

Session 1-3: Transdermal Delivery

Time: 13:30-17:10, July 13, 2017 (Thursday)

Place: Prague A, 2nd Floor, Vienna House Diplomat Prague

Chair Dr. Josef Jampilek, Professor, Comenius University, Slovakia
Co-chair Dr. Gabriele Blume, Director, R&D, Sopharcos, Germany
13:30-13:55   Title: Effect of Piperazine-2, 5-diones on Enhancement Transdermal Permeation of Drugs
Dr. Josef Jampilek, Professor, Comenius University, Slovakia
13:55-14:20 Title: Extractables and Leachables - Acritical Aspect of Transdermal Products
Dr. Tino Otte,
Senior Scientific Consultant, Intertek (Schweiz) AG, Switzerland
09:20-09:45 Title: Toward a New Formulation based on Colloidal Apatite Particles for Topical Treatment of Acne
Dr. Audrey Tourrette,
Associate Professor, CIRIMAT Laboratory, Paul Sabatier University, France
14:45-15:10

Title: Prediction and Mechanism Elucidation of Analyte Retention on Phospholipid Stationary Phases (IAM-HPLC) by in Silico Calculated Physico-chemical Descriptors
Dr. Giacomo Russo,
Researcher, University of Naples Federico II, Italy
 

15:10-15:30 Coffee Break
 15:30-15:55 Title: New multiple Nanoemulsion “Hydro-Tops” for Dermal Drug Delivery – An Alternative to Liposomes
Dr. Gabriele Blume,
Director, R&D, Sopharcos, Germany
 15:55-16:20   Title: Microemulsion Formulations for CZ48, Lactone-stabilized Camptothecin-C20-Propionate for Transdermal Delivery
Dr. Yousif Rojeab, Associate Professor, Ohio Northern University, USA
 
 16:20-16:45   Title: Utilization of Transdermal Microdialysis Technique for Testing Drug Penetration and Drug-drug Interactions at the Dermal Barrier
Dr. Franciska Erdo,
Head, Laboratory of Microdialysis, Pázmány Péter Catholic University, Hungary
 
 16:45-17:10   Title: An Integrated Platform for in-silico Design and Development of Transdermal Drug Delivery Systems
Dr Beena Rai,
Principal Scientist & Head, Physical Sciences; TCS Research, Tata Research Development & Design Centre, India
 

 

 

 

Time arrangement in final program is subject to change without notice.

News Updates

· Early Bird Registration!
· Speaking Proposals Accepted Now!
· Submit the Abstract Right Now!

Hosting Organization

whtslogo.JPG
World High Technology Society (WHTS)

Operating Organization

BIT Group Global Ltd.

Official Travel Agency

BIT World Travel Service, Inc.

Media Partners

BIT's Upcoming Events


Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2016-2017 BIT Group Global Ltd.